Drug intelligence / Profile preview

CystiRelief+

Development stage
Unknown
Lead developer
Tyros Biopharma
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

CystiRelief+ (marketed as URIEXO CystiRelief+) is an over-the-counter oral combination product developed by Tyros Biopharma for the symptomatic relief of burning pain and stinging discomfort associated with cystitis (bladder inflammation) in adult women. The formulation contains two active ingredients: sodium citrate (4 g) and cranberry fruit extract (275 mg). Sodium citrate acts as a urinary alkalizing agent that increases urine pH, thereby reducing the acidity of the urine and alleviating the painful, burning sensations during urination. Cranberry fruit extract provides a source of antioxidants and supports overall urinary tract health. CystiRelief+ is supplied as a powder in convenient single-dose sachets to be dissolved in water, offering a fast-acting, non-prescription, and antibiotic-free option for managing acute cystitis symptoms.

Brand names
CystiRelief+Cystitis supportURIEXO CystiCare +URIEXO CystiCare PlusURIEXO CystiDouleur PlusURIEXO CystiPainURIEXO CystiPain PlusURIEXO CystiReliefURIEXO CystiRelief +URIEXO CystiRelief PlusURIEXO CystiSoin +URIEXO CystiSoin PlusURIEXO CystiSoulageURIEXO CystiSoulage +
Other names
sodium citrate + cranberrysodium citrate + cranberry fruit
02

Targets

CA4 (Carbonic anhydrase 4)P fimbriae

Beyond the preview

Go deeper on CystiRelief+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CystiRelief+.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call